Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Hyperlipoproteinemias

Free Subscription 05.01.2026 1 Atherosclerosis 1 J Cardiovasc Pharmacol 1 Metabolism 3 N Engl J Med 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Atherosclerosis

1. DALEY D, Ayoub A, Akyea RK, L'Esperance V, et al
   Systematic identification of familial hypercholesterolaemia: An updated systematic review and meta-analysis.
   Atherosclerosis. 2025;413:120625.
   PubMed         Abstract available
   
   

   
   J Cardiovasc Pharmacol

2. JALAL AA, Hussain SI, Siddiqui E, Khan MS, et al
   Efficacy and Safety of Oral PCSK9 Inhibitors in Adults with Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
   J Cardiovasc Pharmacol. 2025 Dec 30. doi: 10.1097/FJC.0000000000001789.
   PubMed         Abstract available
   
   

   
   Metabolism

3. FAN G, Guo W, Lu J, He Y, et al
   CADD-engineered peptide protacs efficiently target PCSK9 for hypercholesterolemia in vivo.
   Metabolism. 2025 Dec 23:156485. doi: 10.1016/j.metabol.2025.156485.
   PubMed         Abstract available
   
   

   
   N Engl J Med

4. BERGMARK BA, Marston NA, Sabatine MS
   Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia. Reply.
   N Engl J Med. 2026;394:99.
   PubMed        
   
   
5. TOMLINSON B
   Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
   N Engl J Med. 2026;394:99.
   PubMed        
   
   
6. PERLEMUTER G, Voican C
   Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia.
   N Engl J Med. 2026;394:98-99.
   PubMed        
   
   

   
   Proc Natl Acad Sci U S A

7. YANG Y, Beigneux AP, Lowe TL, Chen YQ, et al
   A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia.
   Proc Natl Acad Sci U S A. 2026;123:e2528664123.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.